We discover genes including several transcriptional modulators, e.g., PRPF4B, BPTF, and BUD31, that define TNBC migratory programs and metastasis formation, which are associated with poor clinical outcome of breast cancer and share signaling networks underlying prognostic gene signatures for primary breast cancer. Here, BUD31 is linked to breast cancer.